Current use of probiotics to prevent necrotising enterocolitis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 104, Issue 2, 2019, Pages F228-

  Duffield, Samuel David ^a   Clarke, Paul ^a,b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

microbiome; NEC; preterm; very low birth weight

Indexed keywords

INFLORAN; LABINIC DROPS; PROBIOTIC AGENT;

BIFIDOBACTERIUM; CLINICAL PRACTICE; DRUG USE; HUMAN; INCIDENCE; LACTOBACILLUS ACIDOPHILUS; LETTER; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED KINGDOM; BIFIDOBACTERIUM BREVE; NEWBORN; NEWBORN INTENSIVE CARE; STATISTICS AND NUMERICAL DATA; VERY LOW BIRTH WEIGHT;

BIFIDOBACTERIUM BREVE; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; LACTOBACILLUS ACIDOPHILUS; PROBIOTICS; UNITED KINGDOM;

EID: 85057090998     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2018-316199     Document Type: Letter

References (7)

1. Battersby C, Longford N, Mandalia S, et al. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study. Lancet Gastroenterol Hepatol 2017;2:43-51.
2. Chang HY, Chen JH, Chang JH, et al. Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis. PLoS One 2017;12:e0171579.
3. Thomas JP, Raine T, Reddy S, et al. Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review. Acta Paediatr 2017;106:1729-41.
4. Sesham R, Oddie S, Embleton ND, et al. Probiotics for preterm neonates: parents' perspectives and present prevalence. Arch Dis Child Fetal Neonatal Ed 2014;99:F345.
5. Costeloe K, Hardy P, Juszczak E, et al. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-60.
6. Härtel C, Pagel J, Rupp J, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr 2014;165:285-9.
7. Denkel LA, Schwab F, Garten L, et al. Protective Effect of Dual-Strain Probiotics in Preterm Infants: A Multi-Center Time Series Analysis. PLoS One 2016;11:e0158136.